Stay updated on CC-486 and MK-3475 in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the CC-486 and MK-3475 in Lung Cancer Clinical Trial page.

Latest updates to the CC-486 and MK-3475 in Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check36 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check65 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check79 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial involving CC-486 and pembrolizumab for non-small cell lung cancer. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference39%
- Check86 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 18, 2025.SummaryDifference0.1%
Stay in the know with updates to CC-486 and MK-3475 in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-486 and MK-3475 in Lung Cancer Clinical Trial page.